This work will offer the first evidence about the relationship between an animal model of endogenous depression
and a frustration model.
Medical illness such as stroke, heart attack, cancer, parkinson's disease and hormonal disorder can cause endogenous depression
making the sick person apathetic and unwilling to care for his physical need, this prolongs the recovery period.
There is evidence indicating that people with endogenous depression
present abnormalities in REM sleep associated with a non suppressive response to DST, and higher basal levels of cortisol (Asnis et al.
The use of lithium in affective disorders, I: acute endogenous depression
Pharmacotherapy to remedy imbalances in neuro-transmitters which that underlie endogenous depression
, or reduce symptoms of exogenous depression to make it easier for individuals to resolve external factors, and traditional psychotherapy to reduce cognitions and behaviors that support depressive symptomatology and promote alternative cognitions and behaviors, have been the principal modes of treatment for clinical depression.
The only studies that found them no more efficacious than SSRIs failed to separate relevant subgroups--such as inpatients or those with severe melancholic or endogenous depression
A survey of New York hospitals in 1975/76 indicated primary use by physicians for endogenous depression
, and secondary use with clients who had previously failed to respond to psychotropic drugs (Asnis, Fink, & Saferstein, 1978).
When a person suffers a bout of endogenous depression
this is primarily a chemical or biological complaint which is often provoked by traumatic events.
Reactive and endogenous depression
: Reactive depression is caused by the person's response to external events while endogenous depression
has no obvious external cause.
This work may thus underestimate the role of stressful events in initiating endogenous depression
, conclude George William Brown, a psychologist at the University of London, and his coworkers.
8] These characteristics include: (a) clinical presentations associated with poor efficacy of monotherapy antidepressant treatment, such as atypical depressive symptoms, endogenous depression
, chronic depression (duration of disease greater than 2 years), or 'double depression' (concurrent depressive episode and dysthymia symptoms); (b) comorbid chronic physical conditions or mental conditions such as drug dependence, anxiety disorder, and borderline personality disorder; and (c) a poor social support system resulting in insufficient management and monitoring of treatment adherence.